All Biotechnology articles
-
OpinionFive more compliance triumphs of 2024
Whether you’re a multinational telecommunications company looking to certify your anti-corruption program post-settlement, or a biochemical company victimized by a “rogue” employee, seeing the light at the end of the enforcement tunnel isn’t always easy.
-
Blog
Xilio Therapeutics appoints CLO
Biotechnology company Xilio Therapeutics announced the appointment of Caroline Hensley as chief legal officer.
-
Blog
Vera Therapeutics appoints legal chief
Biotechnology company Vera Therapeutics announced the appointment of Jason Carter as chief legal officer.
-
Blog
Mestag Therapeutics names GC
Biotech company Mestag Therapeutics announced that it has appointed Alison Hood as general counsel.
-
Blog
Illumina names acting GC
Illumina, a DNA sequencing and array-based technologies firm, announced that Scott Davies has been named acting general counsel and secretary as Charles Dadswell will step down.
-
Blog
Prilenia appoints chief legal officer
Biotechnology company Prilenia Therapeutics B.V. announced the appointment of Jason Marks, J.D. as chief legal officer.
-
Blog
Clarivate names chief administrative, legal officer
Clarivate appointed Melanie Margolin to the expanded role of chief administrative and legal officer.
-
Blog
Flagship Pioneering announces general counsel
Bioplatform innovation company Flagship Pioneering announced that Dina Ciarimboli has been appointed as general counsel and executive partner.
-
Blog
Avalo Therapeutics announces legal chief
Avalo Therapeutics announced that Paul Varki has joined the company as its chief legal officer.
-
Blog
Seismic Therapeutic names general counsel
Seismic Therapeutic announced the appointment of Brendan St. Amant as general counsel.
-
Blog
Aspira Women’s Health general counsel, CCO to resign
Biotechnology company Aspira Women’s Health announced Minh Merchant will resign as general counsel, chief compliance officer, and corporate secretary.
-
Blog
Gamida Cell chief compliance officer to depart
Cell therapy company Gamida Cell announced General Counsel and Chief Compliance Officer Josh Patterson will depart the company.
-
Blog
FibroBiologics names general counsel
Biotechnology company FibroBiologics announced the appointment of Ruben Garcia as general counsel.
-
Blog
Advarra names general counsel
Clinical research review services firm Advarra announced the hiring of Marco Capasso as general counsel and secretary of the board.
-
Blog
EnGene Holdings announces legal chief
EnGene Holdings, a clinical-stage genetic medicines company, announced the appointment of Lee Giguere as chief legal officer and corporate secretary.
-
Blog
Vitro Biopharma adds Crown Resorts legal, compliance chief to board
Biotechnology company Vitro Biopharma announced the appointment of Anthony Pearl, the chief legal and compliance officer of Australian gaming and entertainment group Crown Resorts, as an independent director to its board.
-
Blog
FluidForm Bio welcomes general counsel
Biotechnology company FluidForm Bio announced it named Jonathan Paris as general counsel and head of corporate strategy.
-
Blog
Bicara Therapeutics appoints chief legal officer
Biotechnology company Bicara Therapeutics announced the appointment of Lara Meisner as chief legal officer.
-
PremiumMoney, size, industry: Multiple factors at play in setting compliance reporting lines
Compliance teams most often report to their firm’s legal department, our “Inside the Mind of the CCO” survey found. However, heavily regulated companies and those with fewer employees saw different trends emerge.
-
PremiumTop ethics and compliance failures of 2023
A virtual currency exchange that sought to mislead regulators, banks failing after ignoring obvious risks, and a manufacturer that sold millions of its products in violation of U.S. export controls are among those that make up CW’s list of the biggest ethics and compliance fails of 2023.